Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repurposing Slow-Release Oral Morphine as a New Oral Alternative for the Treatment of Opioid Use Disorder

NCT03948464 is registered in ClinicalTrials.gov with M. Eugenia Socias as lead sponsor.

NCT NCT03948464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03948464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repurposing Slow-Release Oral Morphine as a New Oral Alternative for the Treatment of Opioid Use Disorder
Lead sponsor
M. Eugenia Socias
Phase
Phase 3
Overall status
Terminated
Start date
December 6, 2019
Completion date
June 1, 2020
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fentanyl, methadone, morphine, opiate substitution treatment, opioid-related disorders